首页 工具
登录
抗体

抗体

单克隆抗体是由单个B 淋巴细胞克隆所分泌的抗体,由于B 淋巴细胞只能产生一种专有的、针对一种抗原决定簇的抗体,所以具有理化性质高度专一、生物活性单一、与抗原结合特异性强等特点。因此,它也被形象地被称为“生物导弹”, 现有的抗体药物大多属于此类抗体。近年来,单克隆抗体药物迅速发展,并逐渐成为生物医药领域发展的主要方向。

TargetMol可为您提供30多种抗体抑制剂,满足您的实验需求。TargetMol始终致力于服务“科研人员”,将热门的研究报道和产品推送给各位科研人员。

Cat. No. Product Name CAS No. Purity Chemical Structure
T36653 Anti-SARS-80R mAb
Anti-SARS-80R mAb
98%
Anti-SARS-80R mAb (SARS-80R) is a human IgG1 monoclonal antibody that is derived from CHO cells. Its main function is to selectively bind to the Spike (S1) prote...
T36654 Anti-SARS-CoV-2 Spike mAb (CR3022)
Anti-SARS-CoV-2 Spike mAb (CR3022)
98%
Anti-SARS-CoV-2 Spike mAb (CR3022) is a human monoclonal IgG1 antibody derived from CHO cells. It specifically targets the S1 domain of the Spike protein in both...
T35394 Sintilimab (anti-PD-1)
Sintilimab (anti-PD-1)
98%
Sintilimab (anti-PD-1, IBI 308) 是一种全人源 IgG4 单克隆抗体,可与 T 细胞表面的 PD-1结合,阻断 PD-1/PD-配体 1 (PD-L1) 通路,并重新激活 T 细胞以杀死癌细胞。
T9914 Vedolizumab
维多珠单抗
943609-66-3 98%
Vedolizumab 是一种人源化单克隆抗体,靶向α4β7整联蛋白,用于溃疡性结肠炎和克罗恩病的相关研究。
T35397 Sacituzumab (anti-Trop-2)
Sacituzumab (anti-Trop-2)
1796566-95-4 98%
Sacituzumab 是一种人源化 IgG1 单克隆抗体,与抗滋养层细胞表面抗原 2 (anti-Trop-2) 结合。Sacituzumab 具有用于转移性三阴性乳腺癌研究的潜力。
T11126 Durvalumab
德瓦鲁单抗
1428935-60-7 98%
Durvalumab is an anti-PD-L1 monoclonal antibody, humanized.Durvalumab completely blocked the binding of PD-L1 to PD-1 and CD80, and the IC50s were 0.1 and 0.04 n...
T9923 Nimotuzumab
尼妥珠单抗
828933-51-3 98%
Nimotuzumab 是一种针对表皮生长因子受体 EGFR 的人源化治疗性单克隆抗体。
T36651 Anti-MERS-2E6 mAb
Anti-MERS-2E6 mAb
98%
Anti-MERS-2E6 mAb (MERS-2E6), a human IgG1 neutralizing antibody, is expressed in CHO cells. It effectively competes with the virus Spike protein for binding to ...
T9904 Bevacizumab
贝伐珠单抗
216974-75-3 98%
Bevacizumab 是人源化的单克隆抗体,能够高亲和力的、特异性的与所有 VEGF-A 结合。
T38951 Isatuximab
Isatuximab
1461640-62-9 98%
Isatuximab is a monoclonal antibody targeting the transmembrane receptor and ectoenzyme CD38 , a protein highly expressed on hematological malignant cells, inclu...
T36655 Anti-Spike-RBD mAb
Anti-Spike-RBD mAb
98%
Anti-Spike-RBD mAb is a CHO cell derived human monoclonal IgG1 antibody. Blocking the interaction of spike protein and ACE2 is a potential therapeutic approach f...
T9922 Matuzumab
马妥珠单抗
339186-68-4 98%
Matuzumab 是一种用于癌症治疗的人源化单克隆抗体。它对 EGFR 具有高亲和力,通常与恶性肿瘤中血管的生长有关,从而促进肿瘤的生长和存活。
T35389 Sarilumab (anti-IL-6Rα)
Sarilumab (anti-IL-6Rα)
98%
Sarilumab (anti-IL-6Rα)是人源anti-IL-6Rα单克隆抗体,与膜结合的和可溶性的IL-6Rα以高亲和力结合。MW: 144.13 KD。
T36656 Anti-Spike-RBD Single Domain mAb
Anti-Spike-RBD Single Domain mAb
98%
The Anti-Spike-RBD Single Domain mAb is a monoclonal antibody derived from CHO cells in Alpaca. It is composed of VHH-huFc and exhibits a strong affinity for the...
T12706 Reslizumab
化合物 T12706
241473-69-8 98%
Reslizumab is humanized monoclonal antibodies that target interleukin-5 (IL-5) for the treatment of eosinophilic asthma.
T39057 Rozanolixizumab
Rozanolixizumab
1584645-37-3 98%
Rozanolixizumab (UCB7665) is a humanized monoclonal antibody (IgG4P) that exhibits high affinity for the human neonatal Fc receptor (FcRn). Its application lies ...
T9931 Meplazumab
化合物meplazumab
2413715-21-4 98%
meplazumab 是一种人源化抗 CD147 抗体,作为 COVID-19 肺炎患者的附加疗法。
T36652 Anti-MERS-3A1 mAb
Anti-MERS-3A1 mAb
98%
Anti-MERS-3A1 mAb (MERS-3A1) is a high-affinity human monoclonal IgG1 antibody derived from CHO cells. It effectively inhibits the interaction between the MERS-C...
T35396 Spartalizumab (anti-PD-1)
Spartalizumab (anti-PD-1)
98%
Spartalizumab (anti-PD-1)是一种针对PD-1的人源IgG4抗体,抑制PD-L1和PD-L2与PD-1的结合。PDR001可与PD-1以高亲和力结合,抑制其生物活性;MW: 145.8 KD。
T9917 Denosumab
地诺单抗
615258-40-7 98%
Denosumab 是能够结合并抑制RANKL 受体激活因子的人单克隆抗体。它具有抗癌活性,可降髋部、低椎骨以及非椎骨骨折的风险。
Anti-SARS-80R mAb
T36653
Anti-SARS-80R mAb (SARS-80R) is a human IgG1 monoclonal antibody that is derived from CHO cells. Its main function is to selectively bind to the Spike (S1) prote...
Anti-SARS-CoV-2 Spike mAb (CR3022)
T36654
Anti-SARS-CoV-2 Spike mAb (CR3022) is a human monoclonal IgG1 antibody derived from CHO cells. It specifically targets the S1 domain of the Spike protein in both...
Sintilimab (anti-PD-1)
T35394
Sintilimab (anti-PD-1, IBI 308) 是一种全人源 IgG4 单克隆抗体,可与 T 细胞表面的 PD-1结合,阻断 PD-1/PD-配体 1 (PD-L1) 通路,并重新激活 T 细胞以杀死癌细胞。
Vedolizumab
T9914
Vedolizumab 是一种人源化单克隆抗体,靶向α4β7整联蛋白,用于溃疡性结肠炎和克罗恩病的相关研究。
Sacituzumab (anti-Trop-2)
T35397
Sacituzumab 是一种人源化 IgG1 单克隆抗体,与抗滋养层细胞表面抗原 2 (anti-Trop-2) 结合。Sacituzumab 具有用于转移性三阴性乳腺癌研究的潜力。
Durvalumab
T11126
Durvalumab is an anti-PD-L1 monoclonal antibody, humanized.Durvalumab completely blocked the binding of PD-L1 to PD-1 and CD80, and the IC50s were 0.1 and 0.04 n...
Nimotuzumab
T9923
Nimotuzumab 是一种针对表皮生长因子受体 EGFR 的人源化治疗性单克隆抗体。
Anti-MERS-2E6 mAb
T36651
Anti-MERS-2E6 mAb (MERS-2E6), a human IgG1 neutralizing antibody, is expressed in CHO cells. It effectively competes with the virus Spike protein for binding to ...
Bevacizumab
T9904
Bevacizumab 是人源化的单克隆抗体,能够高亲和力的、特异性的与所有 VEGF-A 结合。
Isatuximab
T38951
Isatuximab is a monoclonal antibody targeting the transmembrane receptor and ectoenzyme CD38 , a protein highly expressed on hematological malignant cells, inclu...
Anti-Spike-RBD mAb
T36655
Anti-Spike-RBD mAb is a CHO cell derived human monoclonal IgG1 antibody. Blocking the interaction of spike protein and ACE2 is a potential therapeutic approach f...
Matuzumab
T9922
Matuzumab 是一种用于癌症治疗的人源化单克隆抗体。它对 EGFR 具有高亲和力,通常与恶性肿瘤中血管的生长有关,从而促进肿瘤的生长和存活。
Sarilumab (anti-IL-6Rα)
T35389
Sarilumab (anti-IL-6Rα)是人源anti-IL-6Rα单克隆抗体,与膜结合的和可溶性的IL-6Rα以高亲和力结合。MW: 144.13 KD。
Anti-Spike-RBD Single Domain mAb
T36656
The Anti-Spike-RBD Single Domain mAb is a monoclonal antibody derived from CHO cells in Alpaca. It is composed of VHH-huFc and exhibits a strong affinity for the...
Reslizumab
T12706
Reslizumab is humanized monoclonal antibodies that target interleukin-5 (IL-5) for the treatment of eosinophilic asthma.
Rozanolixizumab
T39057
Rozanolixizumab (UCB7665) is a humanized monoclonal antibody (IgG4P) that exhibits high affinity for the human neonatal Fc receptor (FcRn). Its application lies ...
meplazumab
T9931
meplazumab 是一种人源化抗 CD147 抗体,作为 COVID-19 肺炎患者的附加疗法。
Anti-MERS-3A1 mAb
T36652
Anti-MERS-3A1 mAb (MERS-3A1) is a high-affinity human monoclonal IgG1 antibody derived from CHO cells. It effectively inhibits the interaction between the MERS-C...
Spartalizumab (anti-PD-1)
T35396
Spartalizumab (anti-PD-1)是一种针对PD-1的人源IgG4抗体,抑制PD-L1和PD-L2与PD-1的结合。PDR001可与PD-1以高亲和力结合,抑制其生物活性;MW: 145.8 KD。
Denosumab
T9917
Denosumab 是能够结合并抑制RANKL 受体激活因子的人单克隆抗体。它具有抗癌活性,可降髋部、低椎骨以及非椎骨骨折的风险。
1 2 3
联系我们
400-820-0310

上海市静安区江场三路238号8楼